Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects - 05/05/16
, Sonia Cajigal, MD b, Edward L. Peterson, PhD a, Brian K. Ahmedani, PhD c, Rajesh Kumar, MD d, David E. Lanfear, MD, MS b, Esteban G. Burchard, MD, MPH e, f, L. Keoki Williams, MD, MPH b, cAbstract |
Background |
Inhaled corticosteroids (ICSs) are the preferred treatment for achieving asthma control. However, little is known regarding the factors contributing to treatment response and whether treatment response differs by population group.
Objective |
We sought to assess behavioral, sociodemographic, and genetic factors related to ICS response among African American and European American subjects with asthma.
Methods |
Study participants were part of the Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-ethnicity (SAPPHIRE). The analytic sample included asthmatic subjects aged 12 to 56 years with greater than 12% bronchodilator reversibility and percent predicted FEV1 of between 40% and 90%. Participants received 6 weeks of inhaled beclomethasone dipropionate. The primary measure of ICS response was a change in Asthma Control Test (ACT) score; the secondary measure was a change in prebronchodilator FEV1. Adherence was measured with electronic monitors. Genetic ancestry was estimated for African American participants by using genome-wide genotype data.
Results |
There were 339 study participants; 242 self-identified as African American and 97 as European American. Baseline ACT score, percent predicted FEV1, degree of bronchodilator response, and ICS adherence were significantly associated with ICS response. A baseline ACT score of 19 or less was useful in identifying those who would respond, as evidenced by the significant dose-response relationship with ICS adherence. Neither self-reported race-ethnicity among all participants nor proportion of African ancestry among African American participants was associated with ICS responsiveness.
Conclusions |
Our findings suggest that baseline lung function measures and self-reported asthma control predict ICS response, whereas self-reported race-ethnicity and genetic ancestry do not.
Le texte complet de cet article est disponible en PDF.Key words : Inhaled corticosteroids, Adherence, medication, asthma, African Continental Ancestry Group, respiratory function tests
Abbreviations used : ACT, BMI, ICS, SAPPHIRE
Plan
| Supported by grants from the American Asthma Foundation (to E.G.B. and L.K.W.), the Flight Attendant Medical Research Institute (to E.G.B.), the Fund for Henry Ford Hospital (to D.E.L., B.K.A., and L.K.W.), the Robert Wood Johnson Foundation Amos Medical Faculty Development Program (to E.G.B.), the Sandler Foundation (to E.G.B.), and the following institutes of the National Institutes of Health: the National Institute of Allergy and Infectious Diseases (AI077439 to E.G.B. and AI079139 and AI061774 to L.K.W.); the National Heart, Lung, and Blood Institute (K23HL093023 to R.K., HL078885 and HL088133 to E.G.B. and HL118267 and HL079055 to L.K.W.); the National Institute of Environmental Health Sciences (ES015794 to E.G.B.); and the National Institute of Diabetes and Digestive and Kidney Diseases (DK064695 to L.K.W.). |
|
| Disclosure of potential conflict of interest: E. L. Peterson has received grants from the National Institutes of Health (NIH). B. K. Ahmedani has received grants from the NIH and the Fund for Henry Ford Hospital. L. K. Williams has received grants from the National Heart, Lung, and Blood Institute; the National Institute of Allergy and Infectious Diseases; the National Institute of Diabetes and Digestive and Kidney Diseases; and the American Asthma Foundation. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 137 - N° 5
P. 1364 - mai 2016 Retour au numéro
Article précédent
- The Editors' Choice
- Cezmi A. Akdis, Zuhair K. Ballas, Associate Editors of the JACI
- Comparative safety and costs of stepping down asthma medications in patients with controlled asthma
- Matthew A. Rank, Juliette T. Liesinger, Megan E. Branda, Michael R. Gionfriddo, Michael Schatz, Robert S. Zeiger, Nilay D. Shah
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?